SCHEMBL8577127

SCHEMBL8577127

CCCCN(CC(F)(F)F)C(=O)C1c2ccccc2-c2cccc(-n3cnc(NC(=O)c4ccccc4Oc4ccccc4)c3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ MTTP P55157 2/20 0.32
▸ AGTR1 P30556 1/20 0.32
▸ AGTR2 P50052 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ LPAR1 Q92633 1/20 0.31
▸ LPAR5 Q9H1C0 1/20 0.31
▸ F2R P25116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8578876 0.89 HDAC1 (0.34) LMNAMAPTTSHRNPSR1RAB9A
SCHEMBL8574660 0.88 LMNA (0.38) LMNAMAPTGAATSHRNPSR1
SCHEMBL8573351 0.82 MAPT (0.41) LMNAMAPTNPSR1L3MBTL1RXFP1
SCHEMBL8577131 0.81 GAA (0.34) LMNAMAPTGAATSHRNPSR1
SCHEMBL8717983 0.81 CCR3 (0.43) LMNAMAPTTSHRNPSR1L3MBTL1
SCHEMBL8573191 0.80 GAA (0.36) LMNAMAPTGAATSHRNPSR1
SCHEMBL8668018 0.80 MAPT (0.39) LMNAMAPTGAATSHRNPSR1
SCHEMBL8665515 0.80 CCR3 (0.41) LMNAMAPTNPSR1L3MBTL1
SCHEMBL8482395 0.79 MAPT (0.38) LMNAMAPTGAATSHRNPSR1
SCHEMBL8712537 0.79 CCR3 (0.43) LMNAMAPTNPSR1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760246-A ANTILIPEMIC AGENTS, ANTICHOLESTEROL AGENTS BRISTOL-MYERS SQUIBB COMPANY 1998-06-02 — — US disclosed
US-H1729-H Method for preparing compounds employing solid phase synthesis and novel linker-resin BRISTOL-MYERS SQUIBB COMPANY (US) 1998-05-05 — — US disclosed
Send feedback